Executive Vice President, Medical
CurrentResponsible for leading Tonix’s clinical development for vaccines and antivirals including our next generation vaccine for smallpox and monkeypox (mpox), TNX-801, our NIH/NIAID Project NextGen selected vaccine for COVID-19, TNX-1800. Lead Medical Affairs for marketed CNS migraine drugs Tosymra and Zembrace. Provide leadership in FDA submissions, clinical trial design and CRO management.